摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2E)-3-(3,4-二羟基苯基)-2-丙烯酰基]酪氨酸 | 124027-56-1

中文名称
N-[(2E)-3-(3,4-二羟基苯基)-2-丙烯酰基]酪氨酸
中文别名
3,7-二羟基-7-乙基胆烷酸
英文名称
caffeoyl tyrosine
英文别名
(-)-N-[3',4'-dihydroxy-(E)-cinnamoyl]-L-tyrosine;caffeoyl-N-tyrosine;N-(E)-Caffeoyl-L-tyrosine;(2S)-2-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
N-[(2E)-3-(3,4-二羟基苯基)-2-丙烯酰基]酪氨酸化学式
CAS
124027-56-1
化学式
C18H17NO6
mdl
——
分子量
343.336
InChiKey
JRXLVUMFJASLDR-PXYYCUNGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    726.4±60.0 °C(Predicted)
  • 密度:
    1.449±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    127
  • 氢给体数:
    5
  • 氢受体数:
    6

SDS

SDS:fedc924d00e734fdd242170ca0452cba
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    CLIFFORD, MICHAEL N.;KELLARD, BRIAN;AH-SING, ERIC, PHYTOCHEMISTRY, 28,(1989) N, C. 1989-1990
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Isolation, Structure Determination, Synthesis, and Sensory Activity of N-Phenylpropenoyl-l-amino Acids from Cocoa (Theobroma cacao)
    摘要:
    Application of chromatographic separation and taste dilution analyses recently revealed besides procyanidins a series of N-phenylpropenoyl amino acids as the key contributors to the astringent taste of nonfermented cocoa beans as well as roasted cocoa nibs. Because these amides have as yet not been reported as key taste compounds, this paper presents the isolation, structure determination, and sensory activity of these amino acid amides. Besides the previously reported (-)-N-[3',4'-dihydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine (clovamide), (-)-N-[4'-hydroxy-(E)-cinnamoyl]-L-tyrosine (deoxyclovamide), and (-)-N-[3',4'-dihydroxy-(E)-cinnamoyl]-L-tyrosine, seven additional amides, namely, (+)-N-[3',4'-dihydroxy-(E)-cinnamoyl]-L-aspartic acid, (+)-N-[4'-hydroxy-(E)-cinnamoyl]-L-aspartic acid, (-)-N-[3',4'-dihydroxy-(E)-cinnamoyl]-L-glutamic acid, (-)-N-[4'-hydroxy-(E)-cinnamoyl]-L-glutamic acid, (-)-N-[4'-hydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine, (+)-N-[4'-hydroxy-3'-methoxy-(E)-cinnamoyl]-L-aspartic acid, and (+)-N-[(E)-cinnamoyl]-L-aspartic acid, were identified for the first time in cocoa products by means of LC-MS/MS, 1D/2D-NMR, UV-vis, CID spectroscopy, and polarimetry, as well as independent enantiopure synthesis. Using the recently developed half-tongue test, human recognition thresholds for the astringent and mouth-drying oral sensation were determined to be between 26 and 220 mu mol/L (water) depending on the amino acid moiety. In addition, exposure to light rapidly converted these [E]-configured N-phenylpropenoyl amino acids into the corresponding [2]-isomers, thus indicating that analysis of these compounds in food and plant materials needs to be performed very carefully in the absence of light to prevent artifact formation.
    DOI:
    10.1021/jf050458q
点击查看最新优质反应信息

文献信息

  • Structure-activity relationship of clovamide and its related compounds for the inhibition of amyloid β aggregation
    作者:Tatsuhiko Tsunoda、Mio Takase、Hideyuki Shigemori
    DOI:10.1016/j.bmc.2018.04.044
    日期:2018.7
    the structure-activity relationship of clovamide (1) for the inhibition of Aβ aggregation, we synthesized 1 and related compounds 2-11 through reaction between l-DOPA, d-DOPA, l-tyrosine, or l-phenylalanine and caffeic acid, p-coumaric acid, or cinnamic acid, and compounds 12 and 13 were derived from 1. Among tested compounds 1-13, those containing one or two catechol moieties exhibited potent anti-aggregation
    阿尔茨海默氏病(AD)是一种神经退行性疾病,其特征是淀粉样β蛋白(Aβ)聚集。Aβ通过β折叠形成聚集,并诱导针对神经元细胞的细胞毒性。因此,天然存在的化合物抑制Aβ聚集是治疗AD的有前途的策略。我们已经报道了具有两个或多个邻苯二酚部分的咖啡酰奎尼酸和苯乙酮类糖苷强烈抑制了Aβ聚集。从可可豆(Theobroma cacao L.)分离的含有两个邻苯二酚部分的环丙酰胺(1)被认为对Aβ聚集具有预防作用。为了研究氯丁酰胺(1)抑制Aβ聚集的构效关系,我们通过1-DOPA,d-DOPA,l-酪氨酸,或l-苯丙氨酸和咖啡酸,对香豆酸或肉桂酸,化合物12和13衍生自1。在测试的化合物1-13中,含有一个或两个邻苯二酚部分的化合物表现出强的抗聚集活性,而非儿茶酚类相关化合物几乎没有活性。这表明至少一个儿茶酚部分对于抑制Aβ42聚集是必不可少的,并且该活性根据儿茶酚部分的数目而增加。因此,clovamid
  • MICROBIOLOGICAL METHOD FOR SYNTHESIZING CINNAMOYL AMIDE DERIVATIVES OF AMINO ACIDS
    申请人:Lorquin Jean
    公开号:US20120142778A1
    公开(公告)日:2012-06-07
    Method for the microbiological production of cinnamoyl amide derivatives of amino acids, certain products that result therefrom and uses thereof, especially as antioxidants.
    微生物生产氨基酸肉桂酰胺衍生物的方法,以及由此产生的某些产品及其用途,特别是作为抗氧化剂。
  • Hydroxycinnamoyl Amino Acids Conjugates: A Chiral Pool to Distinguish Commercially Exploited Coffea spp.
    作者:Federico Berti、Luciano Navarini、Silvia Colomban、Cristina Forzato
    DOI:10.3390/molecules25071704
    日期:——

    The synthesis of five hydroxycinnamoyl amides (HCAs) was accomplished and their identification and quantification in the green coffee bean samples of Coffea arabica, Coffea canephora, and Coffea liberica was performed. The HCAs p-coumaroyl-N-tyrosine 1b, caffeoyl-N-phenylalanine 2b, caffeoyl-N-tyrosine 3b, and p-coumaroyl-N-tryptophan 4b were characteristic of the C. canephora species while caffeoyl-N-tryptophan 5b was present in both C. canephora and C. arabica, but with higher content in C. canephora. The HCAs presence was also analyzed in C. liberica for the first time and none of the targeted compounds was found, indicating that this species is very similar to C. arabica species. Between C. canephora samples from various origins, significant differences were observed regarding the presence of all the HCAs, with C. canephora from Tanzania containing all five derivatives.

    合成了五种羟基肉桂酰胺(HCAs),并对咖啡属(Coffea arabica,Coffea canephora和Coffea liberica)的绿咖啡豆样品进行了它们的鉴定和定量。HCAs对C. canephora物种具有特征性,其中p-香豆酰-N-酪氨酸1b,咖啡酰-N-苯丙氨酸2b,咖啡酰-N-酪氨酸3b和p-香豆酰-N-色氨酸4b。咖啡酰-N-色氨酸5b存在于C. canephora和C. arabica中,但在C. canephora中含量更高。首次分析了C. liberica中的HCAs存在,并且没有发现任何目标化合物,表明该物种与C. arabica物种非常相似。在来自不同地区的C. canephora样品中,观察到所有HCAs的存在方面存在显着差异,坦桑尼亚的C. canephora含有所有五种衍生物。
  • Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
    申请人:——
    公开号:US20040082664A1
    公开(公告)日:2004-04-29
    The present invention relates to derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition, more particularly the compounds of the present invention specifically inhibit the activation of T lymphocyte by src homology region 2(SH2) domain of T lymphocyte (lck), so that they can be used for the treatment, prevention and/or diagnosis of graft rejection, autoimmune diseases, inflammatory diseases, etc.
    本发明涉及羟基苯基衍生物、其制备方法及其药物组合物,更具体地,本发明的化合物特异性地抑制T淋巴细胞的src同源区域2(SH2)结构域(lck),从而可用于移植排斥、自身免疫性疾病、炎症性疾病等的治疗、预防和/或诊断。
  • Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement
    作者:Jian Fu、Ziyao He、Huixiao Fu、Yufen Xia、Inès N'Go、Huayong Lou、Jinglan Wu、Weidong Pan、Stéphane P. Vincent
    DOI:10.1016/j.bmc.2022.116896
    日期:2022.9
    study, we report on the synthesis of amides derived from rosmarinic acid, their inhibitory effect towards purified UGM using three distinct biochemical assays: FP, HPLC and SPR. The rosmarinic amides generally showed a significantly higher affinity for UGM than the corresponding rosmarinic ester. In particular, compound 5h displayed interesting binding affinity values (Kd = 58 ± 7, 63 ± 9 µM towards
    由于耐药结核病的出现,目前的治疗方法不足,因此缺乏结核病 (TB) 药物开发活动。酶 UDP-吡喃半乳糖变位酶 (UGM) 参与半乳聚糖的生物合成,这对细胞壁完整性和细菌活力至关重要。因此,它的抑制被认为是抗结核药物发现的有利可图的策略。在这项研究中,我们报告了从迷迭香酸衍生的酰胺的合成,它们使用三种不同的生化测定法对纯化的 UGM 的抑制作用:FP、HPLC 和 SPR。与相应的迷迭香酸酯相比,迷迭香酰胺通常对UGM显示出显着更高的亲和力。特别是,化合物5 h显示出有趣的结合亲和力值 ( Kd  = 58 ± 7, 63 ± 9 µM 分别朝向Kp UGM 和Mt UGM)。此外,建立了一种新的 UGM SPR 测定,并证实5小时与 UGM 结合,解离常数为 104.8 ± 6.5 μM。总的来说,这项研究验证了酰胺生物等排策略,该策略已成功实施以从迷迭香酸开发 UGM 抑制剂,为进一步设计新型
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物